Tag: including theUSP

Acute Lymphoblastic Leukemia (ALL) can be an aggressive hematologic disorder and constitutes approximately 25% of cancer diagnoses among children and teenagers. and the development of anti-mTOR compounds are documented, reporting the most relevant results from both preclinical and clinical studies in ALL that have contributed significantly into their efficacy or failure. strong class=”kwd-title” Keywords: Acute…